Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Current Liabilities (2020 - 2025)

Selectis Health's Total Current Liabilities history spans 9 years, with the latest figure at $20.3 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 0.51% year-over-year to $20.3 million; the TTM value through Sep 2025 reached $20.3 million, up 0.51%, while the annual FY2024 figure was $19.6 million, 8.16% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $20.3 million at Selectis Health, down from $21.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $21.5 million in Q1 2025 and bottomed at $4.7 million in Q3 2022.
  • The 5-year median for Total Current Liabilities is $16.9 million (2023), against an average of $14.9 million.
  • The largest annual shift saw Total Current Liabilities plummeted 55.22% in 2022 before it skyrocketed 214.02% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $11.8 million in 2021, then tumbled by 41.9% to $6.8 million in 2022, then soared by 164.97% to $18.1 million in 2023, then rose by 8.16% to $19.6 million in 2024, then rose by 3.42% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Total Current Liabilities are $20.3 million (Q3 2025), $21.2 million (Q2 2025), and $21.5 million (Q1 2025).